Live Attenuated Influenza Vaccine (LAIV) for Children for the Prevention of Influenza Illness in Sweden: A Cost-Effectiveness Analysis

Petter Brodin, Fryderyk Wilczyński, Luca Ricci Pacifici, Peter D. Gabb, Holly Prudden, Giorgia Magnatti, Sara Hallberg, Mikko Tuovinen, Åsa Tormod, Amy Zhou, Klas Bergenheim

Open source

DOI
10.1007/s40121-026-01429-x
Published
2026-08-29
Container
Infectious Diseases and Therapy
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40121-026-01429-x,
  title = {Live Attenuated Influenza Vaccine (LAIV) for Children for the Prevention of Influenza Illness in Sweden: A Cost-Effectiveness Analysis},
  author = {Petter Brodin and Fryderyk Wilczyński and Luca Ricci Pacifici and Peter D. Gabb and Holly Prudden and Giorgia Magnatti and Sara Hallberg and Mikko Tuovinen and Åsa Tormod and Amy Zhou and Klas Bergenheim},
  year = {2026},
  journal = {Infectious Diseases and Therapy},
  doi = {10.1007/s40121-026-01429-x},
  url = {https://doi.org/10.1007/s40121-026-01429-x}
}

RIS

TY  - JOUR
TI  - Live Attenuated Influenza Vaccine (LAIV) for Children for the Prevention of Influenza Illness in Sweden: A Cost-Effectiveness Analysis
AU  - Petter Brodin
AU  - Fryderyk Wilczyński
AU  - Luca Ricci Pacifici
AU  - Peter D. Gabb
AU  - Holly Prudden
AU  - Giorgia Magnatti
AU  - Sara Hallberg
AU  - Mikko Tuovinen
AU  - Åsa Tormod
AU  - Amy Zhou
AU  - Klas Bergenheim
PY  - 2026
JO  - Infectious Diseases and Therapy
DO  - 10.1007/s40121-026-01429-x
UR  - https://doi.org/10.1007/s40121-026-01429-x
ER  - 

APA

Brodin, P., Wilczyński, F., Pacifici, L. R., Gabb, P. D., Prudden, H., Magnatti, G., Hallberg, S., Tuovinen, M., Tormod, Å., Zhou, A., & Bergenheim, K. (2026). Live Attenuated Influenza Vaccine (LAIV) for Children for the Prevention of Influenza Illness in Sweden: A Cost-Effectiveness Analysis. Infectious Diseases and Therapy. https://doi.org/10.1007/s40121-026-01429-x

Source records